Julian Kött

27PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Other law and legal studies not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 01, 2026
Perioperative PD-1-inhibition in melanoma patients - a retrospective analysis from eight German skin cancer centers.

|Feb 04, 2026
Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence.

Julian Kött, Nina Matthes, Alexander T Bauer

|Jan 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis.

Glenn Geidel, Sabrina Bänsch, Laura Adam

|Dec 19, 2025
Direct-to-Consumer Teledermatology for Male Androgenetic Alopecia: Narrative Review.

Finn Abeck, Inga Hansen-Abeck, Julian Kött

|Dec 12, 2025
Circulating Tumor DNA Is Prognostic of Patient Outcome and Enables Therapy Monitoring in Metastatic Uveal Melanoma.

Egle Ramelyte, Julian Kött, Aleigha R Lawless

|Sep 13, 2025
Comprehensive Assessment of Prognostic Factors for Immune-Related Adverse Events in Immune Checkpoint Inhibitor-Treated Melanoma.

Julian Kött, Myriam Merkle, Lina Bergmann

Pageof 5

Frequent Collaborators

16 joint publications

Christoffer Gebhardt

10 joint publications

Glenn Geidel

8 joint publications

Stefan W Schneider

6 joint publications

Klaus Pantel